{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-087126","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.277004+00:00","generated_at":"2026-06-08T03:27:58.665592+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NeuroOne appoints medtech exec Christopher Volker as COO; inducement plan expanded by 420,350 shares","bullets":["Christopher Volker appointed COO effective Nov 10, 2023; formerly Head of Commercial Integration at Abbott and VP/GM International at Cardiovascular Systems.","Volker receives base salary of $288,000, 40% target bonus, and option to purchase 324,560 shares at $1.32 per share.","Inducement plan amended to increase reserved shares from 150,000 to 570,350 to attract qualified employees.","Option vests 25% after one year, then monthly over 36 months; accelerated vesting upon change in control."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-087126","json":"https://secwatch.observer/filing/0001213900-23-087126.json","markdown":"https://secwatch.observer/filing/0001213900-23-087126.md","text":"https://secwatch.observer/filing/0001213900-23-087126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023087126/0001213900-23-087126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023087126/ea188259-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:27:58.665592+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d26d66fbf8","claim":"Christopher R. Volker was appointed as Chief Operating Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.","evidence_excerpt":"Christopher R. Volker, age 52, has been appointed as the Chief Operating Officer of the Company, effective on November 10, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023087126/0001213900-23-087126-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}